China Shineway Pharmaceutical Stock Performance
| CSWYF Stock | USD 1.00 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and China Shineway are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days China Shineway Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, China Shineway is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 3.9 B | |
| Total Cashflows From Investing Activities | 395 M | |
| Free Cash Flow | 609.5 M |
China |
China Shineway Relative Risk vs. Return Landscape
If you would invest 100.00 in China Shineway Pharmaceutical on November 14, 2025 and sell it today you would earn a total of 0.00 from holding China Shineway Pharmaceutical or generate 0.0% return on investment over 90 days. China Shineway Pharmaceutical is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than China, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
China Shineway Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of China Shineway for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for China Shineway Pharm can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| China Shineway Pharm generated a negative expected return over the last 90 days | |
| China Shineway Pharm has some characteristics of a very speculative penny stock | |
| About 66.0% of the company shares are held by company insiders |
China Shineway Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of China Pink Sheet often depends not only on the future outlook of the current and potential China Shineway's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. China Shineway's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 827 M | |
| Dividends Paid | 453.1 M |
China Shineway Fundamentals Growth
China Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of China Shineway, and China Shineway fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on China Pink Sheet performance.
| Return On Equity | 0.0964 | |||
| Return On Asset | 0.0492 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 164.34 M | |||
| Shares Outstanding | 827 M | |||
| Price To Earning | 10.01 X | |||
| Price To Book | 0.90 X | |||
| Price To Sales | 0.24 X | |||
| Revenue | 3.22 B | |||
| EBITDA | 721.36 M | |||
| Cash And Equivalents | 4.21 B | |||
| Cash Per Share | 5.57 X | |||
| Total Debt | 14.91 M | |||
| Debt To Equity | 0 % | |||
| Book Value Per Share | 8.04 X | |||
| Cash Flow From Operations | 703.15 M | |||
| Earnings Per Share | 0.11 X | |||
| Total Asset | 7.2 B | |||
About China Shineway Performance
By analyzing China Shineway's fundamental ratios, stakeholders can gain valuable insights into China Shineway's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if China Shineway has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if China Shineway has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the Peoples Republic of China and Hong Kong. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited. China Shineway operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.Things to note about China Shineway Pharm performance evaluation
Checking the ongoing alerts about China Shineway for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for China Shineway Pharm help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| China Shineway Pharm generated a negative expected return over the last 90 days | |
| China Shineway Pharm has some characteristics of a very speculative penny stock | |
| About 66.0% of the company shares are held by company insiders |
- Analyzing China Shineway's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether China Shineway's stock is overvalued or undervalued compared to its peers.
- Examining China Shineway's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating China Shineway's management team can have a significant impact on its success or failure. Reviewing the track record and experience of China Shineway's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of China Shineway's pink sheet. These opinions can provide insight into China Shineway's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for China Pink Sheet analysis
When running China Shineway's price analysis, check to measure China Shineway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Shineway is operating at the current time. Most of China Shineway's value examination focuses on studying past and present price action to predict the probability of China Shineway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Shineway's price. Additionally, you may evaluate how the addition of China Shineway to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |